Select your location
Search
Search
CAPABILITIES
Close CAPABILITIES
Open CAPABILITIES
Operating Verticals
Branded APIs
IMMANX™
Consumer Brands
Manufacturing
BRAND PORTFOLIO
Close BRAND PORTFOLIO
Open BRAND PORTFOLIO
Division
IMMANX™
Branded APIs
ETRNYA™
Celltria™
AshwaPrime™
VYUEVER™
NAD8™
PepSleep™
Consumer Brands
Longeya™
FOY™
ETRNL™
ETERNIA™
CONTACT
DISCUSS A PARTNERSHIP
Home
Insights
Insights
Insights
Projected Compound Annual Growth Rate (CAGR) of Global Pharmaceutical Spending from 2023 to 2027: Analysis by Market and Product Types
QuadroPharma
-
June 20, 2024
0
Insights
Global pharmaceutical sales from 2020 to 2023, by region
QuadroPharma
-
June 19, 2024
0
Insights
Global sales of branded prescription drugs (excluding generics and orphan drugs) are projected to span from 2012 to 2026.
QuadroPharma
-
June 18, 2024
0
Insights
Pharmaceutical R&D Spending: Global Trends from 2014 to 2028
QuadroPharma
-
June 16, 2024
0
Insights
Global Market Forecast 2027: Leading Therapy Classes by Spending
QuadroPharma
-
June 15, 2024
0
Insights
Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2024
QuadroPharma
-
June 14, 2024
0
Find more information about QuadroPharma in your location.
CloseMenu
North America
United States
Middle East
United Arab Emirates
